Related Experiment Videos
Dose effects of temazepam tablets on sleep
Drugs Under Experimental and Clinical Research
|January 1, 1986
Summary
Temazepam effectively treats insomnia by reducing sleep latency and increasing sleep time. Higher doses (30 mg) showed greater improvements in sleep staging compared to lower doses (15 mg) without causing residual effects.
Area of Science:
- Pharmacology
- Sleep Medicine
- Clinical Trials
Background:
- Sleep onset insomnia is a common sleep disorder.
- Benzodiazepines like temazepam are frequently prescribed for insomnia.
- Understanding dose-dependent effects is crucial for optimizing treatment.
Purpose of the Study:
- To evaluate the dose-dependent effects of temazepam (15 mg and 30 mg) on sleep onset insomnia.
- To compare the efficacy of acute and short-term temazepam treatment.
- To assess for residual effects and withdrawal symptoms.
Main Methods:
- A double-blind, placebo-controlled study was conducted in 48 volunteers with sleep onset insomnia.
- Polysomnography was used to monitor sleep architecture for 8 hours.
- Temazepam (15 mg and 30 mg) or placebo was administered for acute (nights 5-7) and short-term (nights 11-13) treatment periods.
Main Results:
- Both 15 mg and 30 mg of temazepam significantly reduced sleep latency and increased total sleep time compared to placebo.
- The 30 mg dose demonstrated a greater or more consistent effect on sleep staging than the 15 mg dose.
- No significant residual effects on performance or evidence of disturbed sleep upon discontinuation were observed.
Conclusions:
- Temazepam is an effective treatment for sleep onset insomnia, with dose-dependent effects on sleep staging.
- The 30 mg dose appears more potent than the 15 mg dose.
- Temazepam does not appear to cause significant residual effects or withdrawal symptoms in the short term.